EZH2 and familial pancreatic carcinoma: Epigenetic repression of pro-inflammatory SASP genes—such as those encoding CCL2 and CXCL9/10—by enhancer of zeste homolog 2 (EZH2) has been shown to dampen immune cell infiltration in pancreatic cancer models [262].